Literature DB >> 19766078

Translating inflammatory bowel disease research into clinical medicine.

Markus F Neurath1, Susetta Finotto.   

Abstract

Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19766078     DOI： 10.1016/j.immuni.2009.08.016

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  16 in total

1.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

2.  Anti-Fibrotic Potential of All Trans Retinoic Acid in Inflammatory Bowel Disease.

Authors:  Dominick L Auci; Nejat K Egilmez; Gerald W Dryden
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2018-05-28

3.  Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.

Authors:  Dominick L Auci; Nejat K Egilmez
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-08-11

4.  Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.

Authors:  Thomas F Conway; Laura Hammer; Stacia Furtado; Edith Mathiowitz; Ferdinando Nicoletti; Katia Mangano; Nejat K Egilmez; Dominick L Auci
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

5.  Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.

Authors:  Honggang Wang; Jianning Dong; Peiliang Shi; Jianhui Liu; Lugen Zuo; Yi Li; Jianfeng Gong; Lili Gu; Jie Zhao; Liang Zhang; Wei Zhang; Weiming Zhu; Ning Li; Jieshou Li
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

6.  Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases.

Authors:  Dmitriy Gorenshteyn; Elena Zaslavsky; Miguel Fribourg; Christopher Y Park; Aaron K Wong; Alicja Tadych; Boris M Hartmann; Randy A Albrecht; Adolfo García-Sastre; Steven H Kleinstein; Olga G Troyanskaya; Stuart C Sealfon
Journal:  Immunity       Date:  2015-09-08       Impact factor: 31.745

7.  Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn's Disease.

Authors:  Honggang Wang; Lugen Zuo; Jie Zhao; Jianning Dong; Yi Li; Lili Gu; Jianfeng Gong; Qinghong Liu; Weiming Zhu
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

Review 8.  Cytokines and mucosal immunity.

Authors:  Giorgos Bamias; Kristen O Arseneau; Fabio Cominelli
Journal:  Curr Opin Gastroenterol       Date:  2014-11       Impact factor: 3.287

Review 9.  Colitis-associated neoplasia: molecular basis and clinical translation.

Authors:  Sebastian Foersch; Markus F Neurath
Journal:  Cell Mol Life Sci       Date:  2014-05-15       Impact factor: 9.261

10.  Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer.

Authors:  Deborah C Rubin; Anisa Shaker; Marc S Levin
Journal:  Front Immunol       Date:  2012-05-08       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.